Site-specific glycation of Aβ1-42 affects fibril formation and is neurotoxic.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
31 05 2019
Historique:
received: 28 11 2018
revised: 12 04 2019
pubmed: 19 4 2019
medline: 19 2 2020
entrez: 19 4 2019
Statut: ppublish

Résumé

Aβ1-42 is involved in Alzheimer's disease (AD) pathogenesis and is prone to glycation, an irreversible process where proteins accumulate advanced glycated end products (AGEs).

Identifiants

pubmed: 30996005
pii: S0021-9258(20)36402-4
doi: 10.1074/jbc.RA118.006846
pmc: PMC6552435
doi:

Substances chimiques

Amyloid 0
Amyloid beta-Peptides 0
N(6)-carboxyethyllysine 0
Peptide Fragments 0
Protein Aggregates 0
amyloid beta-protein (1-42) 0
Singlet Oxygen 17778-80-2
Lysine K3Z4F929H6

Banques de données

PDB
['2BEG']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8806-8818

Informations de copyright

© 2019 Ng et al.

Références

J Neurochem. 1997 Aug;69(2):581-93
pubmed: 9231715
Neurobiol Dis. 2010 Jan;37(1):67-76
pubmed: 19778613
Trends Mol Med. 2008 Feb;14(2):45-53
pubmed: 18218341
Nat Neurosci. 2019 Mar;22(3):401-412
pubmed: 30742114
Ann N Y Acad Sci. 2005 Jun;1043:211-6
pubmed: 16037241
PeerJ. 2013 May 07;1:e73
pubmed: 23678397
J Pept Res. 2005 Sep;66(3):111-24
pubmed: 16083438
Curr Pharm Des. 2008;14(10):973-8
pubmed: 18473848
J Neurochem. 2005 Jan;92(2):255-63
pubmed: 15663474
Nat Methods. 2017 Jan;14(1):71-73
pubmed: 27819658
Methods Mol Biol. 2012;810:25-58
pubmed: 22057559
Free Radic Res. 2002 Jan;36(1):47-54
pubmed: 11999702
J Biol Chem. 2005 Jun 3;280(22):21522-30
pubmed: 15799962
J Phys Chem B. 2010 Feb 4;114(4):1652-60
pubmed: 20055378
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5710-4
pubmed: 8202552
Biochem J. 1997 Jun 1;324 ( Pt 2):565-70
pubmed: 9182719
Methods Mol Biol. 2013;1078:9-21
pubmed: 23975817
Clin Biochem. 2018 Jun;56:75-82
pubmed: 29680706
J Phys Chem B. 2009 May 14;113(19):6692-702
pubmed: 19419218
Nat Protoc. 2016 Feb;11(2):252-72
pubmed: 26741409
Biochim Biophys Acta. 2008 Sep;1777(9):1092-7
pubmed: 18519024
Proc Natl Acad Sci U S A. 2015 Jun 16;112(24):E3095-103
pubmed: 26038575
J Comput Chem. 2010 Mar;31(4):671-90
pubmed: 19575467
J Biol Chem. 2002 Aug 30;277(35):32046-53
pubmed: 12058030
J Biol Chem. 2018 Aug 24;293(34):13100-13111
pubmed: 29959224
Methods Mol Biol. 2011;670:13-32
pubmed: 20967580
Acc Chem Res. 2016 Oct 18;49(10):2199-2208
pubmed: 27672697
J Neurosci Res. 2002 Apr 1;68(1):89-96
pubmed: 11933053
Neurosci Lett. 1996 Apr 12;208(1):53-6
pubmed: 8731173
Nucleic Acids Res. 2011 Jul;39(Web Server issue):W511-7
pubmed: 21609950
Nat Struct Mol Biol. 2010 May;17(5):561-7
pubmed: 20383142
Redox Biol. 2018 Apr;14:450-464
pubmed: 29080524
Trends Neurosci. 2017 Mar;40(3):151-166
pubmed: 28190529
Front Mol Neurosci. 2017 Mar 08;10:64
pubmed: 28337125
J Biol Chem. 2008 Oct 31;283(44):29639-43
pubmed: 18723507
ACS Chem Neurosci. 2012 Jun 20;3(6):473-81
pubmed: 22860216
Chem Sci. 2017 Oct 1;8(10):7087-7097
pubmed: 29147538
Nat Chem Biol. 2011 Nov 20;8(1):93-101
pubmed: 22101602
FASEB J. 2005 Dec;19(14):2040-1
pubmed: 16210396
Proc Natl Acad Sci U S A. 1994 May 24;91(11):4766-70
pubmed: 8197133
Cytometry. 2002 Apr 1;47(4):236-42
pubmed: 11933013
Cell Mol Biol (Noisy-le-grand). 1998 Nov;44(7):1139-45
pubmed: 9846896
Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17342-7
pubmed: 16293696
Nature. 2006 Oct 19;443(7113):787-95
pubmed: 17051205
Biochem J. 2000 Sep 1;350 Pt 2:381-7
pubmed: 10947951
Free Radic Biol Med. 2001 Jul 15;31(2):175-80
pubmed: 11440829
Am J Pathol. 1998 Oct;153(4):1149-55
pubmed: 9777946
Science. 2006 Nov 3;314(5800):777-81
pubmed: 17082447
Ann Neurol. 2005 May;57(5):695-703
pubmed: 15852400
J Mol Model. 2017 Dec 6;24(1):5
pubmed: 29214361
J Biol Inorg Chem. 2017 Dec;22(8):1211-1222
pubmed: 29038915
Cell Death Dis. 2013 Jun 13;4:e673
pubmed: 23764854
J Neurochem. 2017 Nov;143(4):418-431
pubmed: 28397282

Auteurs

Jin Ng (J)

From the School of Biological Sciences, jin.ng@auckland.ac.nz.
the Brain Research New Zealand Rangahau Roro Aotearoa and Centre for Brain Research, Auckland 1010, and.

Harveen Kaur (H)

From the School of Biological Sciences.
School of Chemical Sciences, and.

Thomas Collier (T)

the Centre for Theoretical Chemistry and Physics, Institute of Natural and Mathematical Sciences, Massey University, Auckland 0632.
the Maurice Wilkins Centre for Molecular Biodiscovery, Auckland 1010, New Zealand.

Kevin Chang (K)

the Statistical Consulting Centre, Department of Statistics, University of Auckland, Auckland 1010.

Anna E S Brooks (AES)

From the School of Biological Sciences.
the Maurice Wilkins Centre for Molecular Biodiscovery, Auckland 1010, New Zealand.

Jane R Allison (JR)

From the School of Biological Sciences.
the Maurice Wilkins Centre for Molecular Biodiscovery, Auckland 1010, New Zealand.

Margaret A Brimble (MA)

From the School of Biological Sciences.
the Brain Research New Zealand Rangahau Roro Aotearoa and Centre for Brain Research, Auckland 1010, and.
School of Chemical Sciences, and.
the Maurice Wilkins Centre for Molecular Biodiscovery, Auckland 1010, New Zealand.

Anthony Hickey (A)

From the School of Biological Sciences, a.hickey@auckland.ac.nz.

Nigel P Birch (NP)

From the School of Biological Sciences.
the Brain Research New Zealand Rangahau Roro Aotearoa and Centre for Brain Research, Auckland 1010, and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH